提出可泛化的纵向医学影像分析框架,提升疾病进展预测准确性。
GLOMIA-Pro: A Generalizable Longitudinal Medical Image Analysis Framework for Disease Progression Prediction
- 设计分段正交注意力与有序约束,分离疾病进展的细微影像变化。
- 引入改进的跳跃连接,缓解相邻时间点图像相似导致的表征坍塌。
- 在骨关节炎和食管癌治疗评估中表现优于7种先进方法,适用性强。
纵向医学影像对监测疾病进展至关重要,能捕捉动态生物过程中的时空变化。现有方法存在三大局限:缺乏适用于多种疾病进展预测任务的通用框架;常忽略疾病分期的序数特性;因相邻时间点结构相似,易引发表征坍塌,掩盖关键进展标志物。为此,我们提出通用型纵向医学影像分析框架GLOMIA-Pro,包含两个核心组件:进展表征提取与进展感知融合。进展表征提取模块引入分段正交注意力机制,并采用新颖的有序进展约束,有效解耦与疾病进展相关的细微时序影像变化。进展感知融合模块设计改进的跳跃连接架构,将学习到的进展表征与当前影像表征融合,显著缓解跨时间融合中的表征坍塌问题。在膝骨关节炎严重程度预测和食管癌治疗反应评估两个临床任务上验证,GLOMIA-Pro持续优于七种先进方法。消融实验进一步确认各组件贡献,证明其在多样化临床场景下的鲁棒性与泛化能力。
原文摘要 · Abstract (English)
Longitudinal medical images are essential for monitoring disease progression by capturing spatiotemporal changes associated with dynamic biological processes. While current methods have made progress in modeling spatiotemporal patterns, they face three key limitations: (1) lack of generalizable framework applicable to diverse disease progression prediction tasks; (2) frequent overlook of the ordinal nature inherent in disease staging; (3) susceptibility to representation collapse due to structural similarities between adjacent time points, which can obscure subtle but discriminative progression biomarkers. To address these limitations, we propose a Generalizable LOngitudinal Medical Image Analysis framework for disease Progression prediction (GLOMIA-Pro). GLOMIA-Pro consists of two core components: progression representation extraction and progression-aware fusion. The progression representation extraction module introduces a piecewise orthogonal attention mechanism and employs a novel ordinal progression constraint to disentangle finegrained temporal imaging variations relevant to disease progression. The progression-aware fusion module incorporates a redesigned skip connection architecture which integrates the learned progression representation with current imaging representation, effectively mitigating representation collapse during cross-temporal fusion. Validated on two distinct clinical applications: knee osteoarthritis severity prediction and esophageal cancer treatment response assessment, GLOMIA-Pro consistently outperforms seven state-of-the-art longitudinal analysis methods. Ablation studies further confirm the contribution of individual components, demonstrating the robustness and generalizability of GLOMIA-Pro across diverse clinical scenarios.
Thank you to arXiv for use of its open access interoperability. PaperDance 不是 arXiv 官方产品;中文卡片由大模型生成,请以原文为准。